Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 241 results found. Search for [ Pfizer ]

Results 1 to 21 of 241
PTI
January 20, 2019
While several top leaders have decided to stay away from Davos, others believe their absence underlines the need for an immediate brain-storming over the imminent risks faced by the world.


PTI
January 20, 2019



PB Jayakumar
New Delhi, January 9, 2019
Ogivri is the biosimilar version of Swiss drug maker Roches Herceptin, a breast cancer and gastric cancer drug with sales of $6.9 billion a year worldwide


PTI
December 24, 2018
Finance Minister Arun Jaitley and two of his union cabinet colleagues are likely to travel to Switzerland's snow-laden resort town of Davos next month for the WEF Annual Meeting


PB Jayakumar
December 19, 2018
Ogivri (Trastuzumab), jointly developed by Biocon and Mylan, is the biosimilar version of Swiss drug maker Roche's Herceptin.


PTI
December 19, 2018



PTI
December 14, 2018



PTI
November 30, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


PTI
November 20, 2018



PTI
November 20, 2018



PTI
November 14, 2018



PTI
October 11, 2018



PTI
October 1, 2018



BusinessToday.In
New Delhi, September 13, 2018
India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.


PB Jayakumar
New Delhi, May 24, 2018
The US FDA recently gave green signal to market IDx-DR, a medical device to detect diabetic retinopathy, a disease in which high blood sugar damages blood vessels in the retina of eyes and leads to the vision loss.


PB Jayakumar
New Delhi, February 21, 2018
The competition to tap large molecule structured complex bio-similars or off-patent biotech drugs is heating up.


www.businesstoday.in
January 31, 2018



PB Jayakumar
New Delhi, January 16, 2018
Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.


PTI
December 16, 2017



PAGES 1 OF 13  12345